WAM
NVO

Weiss Asset Management’s Novo Nordisk NVO Stock Holding History

Weiss Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,232
Closed -$359K – 479
2018
Q3 		$359K Hold
15,232
– – 0.03% 127
2018
Q2 		$351K Hold
15,232
– – 0.03% 126
2018
Q1 		$375K Hold
15,232
– – 0.03% 131
2017
Q4 		$409K Buy
+15,232
New +$387K 0.04% 140

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Weiss Asset Management's NVO Position: Q4 2018 in Review

Weiss Asset Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 15,232 shares — an estimated $359K sold.

Weiss Asset Management first reported a position in NVO in Q4 2017 and held it in 4 quarters. The position peaked at $409K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Weiss Asset Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Weiss Asset Management sold 15,232 Novo Nordisk shares in Q4 2018, an estimated $359K.
  • Weiss Asset Management first reported a position in Novo Nordisk in Q4 2017 and held it in 4 quarters.
  • Weiss Asset Management's Novo Nordisk position peaked at $409K in Q4 2017.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Weiss Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.